Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
Nationaal Kompas Volksgezondheid

Hartfalen

Kort en bondig

De ziekte en de determinanten

Omvang van het probleem

Preventie en zorg

Geografische verschillen

Kijk ook eens bij andere websites:

.

Bronnen en Literatuur

Bronnen

Literatuur

  • Angermann CE, Störk S, Gelbrich G, Faller H, Jahns R, Frantz S, et al.Mode of Action and Effects of Standardized Colaborative Disease Management on Mortality and Morbidity in Patients with Systolic Heart Failure: The Interdisciplinary Networdk for Heart Failure (INH) Study. Circ Heart Fail, 2011; (Sep 28): Epub ahead of print.
  • Anker SD, Koehler F, Abraham WT.Telemedicine and remote management of patients with heart failure. Lancet, 2011; 378(9792): 731-739.
  • Baan CA, Hutten JH, Rijken PM. Afstemming in de zorg. Een achtergrondstudie naar de zorg voor mensen met een chronische aandoening. RIVM-rapport nr. 282701005. Bilthoven: RIVM/NIVEL,2003.
  • Blackledge HM, Tomlinson J, Squire IB.Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12220 index admissions in Leicestershire 1993-2001. Heart, 2003; 89(6): 615-620.
  • Bleumink GS, Knetsch AM, Sturkenboom MCJM, Straus SMJM, Hofman A, Deckers JW, et al.Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. Eur Heart J, 2004; 25: 1614-1619.
  • Cost B, Grobbee DE, Schoot-Van Venrooy J van der, Balk AHMM, Man in t Veld AJ, Prins A.Incidence and risk factors of heart failure. In: Cost B. Heart Failure in the elderly [thesis]. Rotterdam: Erasmus Universiteit Rotterdam, 2000.
  • Cowie MR, Fox KF, Wood DA, Metcalfe C, Thompson SG, Coats AJ, et al.Hopitalization of patients with heart failure. A population-based study. Eur Heart J, 2002; 23: 877-85.
  • Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V, et al.Incidence and aetiology of heart failure. A population-based study. Eur Heart J, 1999; 20: 421-8.
  • Davie AP, Francis CM, Love MP, Caruana L, Starkey IR, Shaw IR, et al.Value of electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ, 1996; 312(7025): 222.
  • Dunlay SM, Redfield MM, Weston SA, Therneau TM, Hall Long K, Shah ND, et al.Hospitalizations after heart failure diagnosis: a community perspective. J Am Coll Cardiol, 2009; 54(18): 1695-1702.
  • Engelfriet PM, Hoogenveen RT, Poos MJJC, Blokstra A, Baal PHM van, Verschuren WMM. Hartfalen: epidemiologie, risicofactoren en toekomst. RIVM-rapport nr. 260401006/2012. Bilthoven,2012b.
  • ESCARDIO, European Society of Cardiology.Guidelines for the diagnosis and treatment of chronic heart failure. Executive summary (update 2005). Task force for the diagnosis and treatment of chronic heart failure. Eur Heart J, 2005; 26: 1115-40.
  • European Society of Cardiology.ESC Guideline for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J, 2008; 29: 2388-2442.
  • Fahey T, Jeyaseelan S, McCowan C, Carr E, Goudie BM, Pringle SD, et al.Diagnosis of left ventricular systolic dysfunction (LVSD): development and validation of a clinical prediction rule in primary care. Fam Pract, 2007; 24(6): 628-635.
  • Faris R, Flather MD, Purcell H, Poole-Wilson PA, Coats AJ.Diuretics for heart failure (review). Cochrane Database Syst Rev, 2006; 1: CD003838.
  • Flynn KE, Piña IL, Whellan DJ, Lin L, Blumenthal JA, Ellis SJ, et al.Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA, 2009; 301(14): 1451-1459.
  • Fox KF, Cowie MR, Wood DA, Coats AJ, Gibbs JS, Underwood SR, et al.Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J, 2001; 22 (3): 228-36.
  • Ho KK, Pinsky JL, Kannel WB, Levy D.The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993b; 22(4 Suppl A): 6A-13A.
  • Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D.Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993a; 88: 107-115.
  • Hoes AW, Walma EP, Rutten FH, Twickler TB, Rohling R, Jansen RWMM, et al.Multidisciplinaire richtlijn Hartfalen 2010. 2010.
  • Hunt SA.ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guideli J Am Coll Cardiol, 2005; 46(6): e1-82.
  • Inglis SC, Clark RA, McAlister FA, Ball J, Lewinter C, Cullington D, et al.Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev, 2010; (8): CD007228.
  • Jaarsma T, Wal MH van der, Lesman-Leegte I, Luttik ML, Hogenhuis J, Veeger NJ, et al.Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med, 2008; 168(3): 316-324.
  • Jaarsveld CH van, Ranchor AV, Kempen GI, Coyne JC, Veldhuisen DJ van, Sanderman R.Epidemiology of heart failure in a community-based study of subjects aged > or = 57 years: incidence and long-term survival. Eur J Heart Fail, 2006; 8(1): 23-30.
  • Jhund PS, Macintyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A.Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation, 2009; 119(4): 515-523.
  • Kannel WB, Ho K, Thom T.Changing epidemiologic features of cardiac failure. Br Heart J 1994; 72: 53-59.
  • Kelder JC, Cowie MR, McDonagh TA, Hardman SM, Grobbee DE, Cost B, et al.Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis. Heart, 2011b; 97(12): 959-963.
  • Kelder JC, Cramer MJ, Wijngaarden J van, Tooren R van, Mosterd A, Moons KG, et al.The Diagnostic Value of Physical Examination and Additional Testing in Primary Care Patients With Suspected Heart Failure. Circulation, 2011a; (Nov 21): Epub ahead of print.
  • Kelder JC, Rutten FH, Hoes AW.Clinically relevant diagnostic research in primary care: the example of B-type natriuretic peptides in the detection of heart failure. Fam Pract, 2009; 26(1): 69-74.
  • Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al.Obesity and the risk of heart failure. N Engl J Med, 2002; 347: 305-313.
  • Khunti K, Squire I, Abrams KR, Sutton AJ.Accuracy of a 12-lead electrocardiogram in screening patients with suspected heart failure for open access echocardiography: a systematic review and meta-analysis. Eur J Heart Fail, 2004; 6(5): 571-576.
  • Lesman-Leegte I, Jaarsma T, Coyne JC, Hillege HL, Veldhuisen DJ van, Sanderman R.Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age- and gender-matched community controls. J Card Fail, 2009; 15(1): 17-23.
  • Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, et al.Long-term trends in the incidence of and survival with heart failure. N Engl J Med, 2002; 347: 1397-402.
  • MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, et al.Evidence of improving prognosis in heart failure: trends in case fatality in 66547 patients hospitalized between 1986 and 1995. Circulation, 2000; 102(10): 1126-1131.
  • Mant J, Doust J, Roalfe A, Barton P, Cowie MR, Glasziou P, et al.Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess, 2009; 13(32): 1-207, iii.
  • McAlister FA, Stewart S, Ferrua S, McMurray JJ.Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol, 2004; 44(4): 810-819.
  • McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD.Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol, 2002; 39: 60-69.
  • Mehta PA, Dubrey SW, McIntyre HF, Walker DM, Hardman SM, Sutton GC, et al.Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK. Heart, 2009; 95(22): 1851-1856.
  • Meta-analysis Global Group in Chronic Heart Failure (MAGGIC).The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J, 2011; (Aug 6): Epub ahead of print.
  • Mosterd A, Hoes AW, Bruijne MC de, Deckers JW, Linker DT, Hofman A, et al.Prevalence of heart failure and left ventricular dysfunction in the general population. The Rotterdam Study. Eur Heart J, 1999c; 20: 447-55.
  • Mosterd A, Hoes AW.Clinical epidemiology of heart failure. Heart, 2007; 93: 1137-1146.
  • Nagueh SF, Bierig SM, Budoff MJ, Desai M, Dilsizian V, Eidem B, et al.American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathie: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, an J Am Soc Echocardiogr, 2011; 24(5): 473-498.
  • Oudejans I, Mosterd A, Bloemen JA, Valk MJ, Velzen E van, Wielders JP, et al.Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests. Eur J Heart Fail, 2011; 13(5): 518-527.
  • Pitt B.Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Mol Cell Endocrinol, 2004; 217(1-2): 53-58.
  • Porte PW de la, Lok DJ, Veldhuisen DJ van, Wijngaarden J van, Cornel JH, Zuithoff NF, et al.Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study. Heart, 2007; 93(7): 819-825.
  • Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ.Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA, 2003; 289: 194-202.
  • Reitsma JB, Mosterd A, Craen AJM de, Koster RW, Capelle FJI van, Grobbee DE, et al.Increase in hospitalisation rates for heart failure in the Netherlands, 1980-1993. Heart, 1996a; 76: 388-92.
  • Rutten FH, Cramer M-JM, Grobbee DE, Sachs APE, Kirkels JH, Lammers J-WJ, et al.Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J, 2005a; 26: 1887-1894.
  • Rutten FH, Moons KGM, Cramer M-JM, Grobbee DE, Zuithoff NPA, Lammers J-WJ, et al.Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ, 2005c; 331: 1379-1386.
  • Rutten FH, Walma EP, Kruizinga GI, Bakx HCA, Lieshout J van.NHG-standaard Hartfalen, eerste herziening. Huisarts Wet, 2005b; 48: 64-76.
  • Rutten FH, Grobbee DE, Hoes AW.Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 2003; 5: 337-344.
  • Senni M, Tribouilloy CM, Rodeheffer RJ, et al.Congestive heart failure in the community: trends in incidence and survival over a 10-year period. Arch Intern Med, 1999; 159: 29-34.
  • Shafazand M, Schaufelberger M, Lappas G, Swedberg K, Rosengren A.Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry. Eur Heart J, 2009; 30(6): 671-678.
  • Slobbe LCJ, Smit JM, Groen J, Poos MJCC, Kommer GJ Kosten van ziekten in Nederland 2007. Trends in de Nederlandse zorguitgaven 1999-2010. Bilthoven: RIVM,2011.
  • The Digitalis Investigation Group.The effect of digitalis on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-533.
  • Zannad F, McMurray JJV, Krum H, Veldhuisen DJ van, Swedberg K, Shi H, et al.Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms. N Engl J Med, 2011; 364: 11-21.
  • Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox K, McDonagh T.The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail, 2005; 7(4): 537-541.

Begrippen en afkortingen

Afkortingen

ACE
Angiotensine converting enzyme
CABG
Coronary artery bypass grafting
Bypass operatie.
CMR
Continue morbiditeitsregistratie
COPD
Chronic obstructive pulmonary disease
Chronische obstructieve longziekten.
COPD
Chronic Obstructive Pulmonary Disease
ECG
Elektrocardiogram
ICD
International Classification of Diseases
Internationale classificatie van ziekten.
ICPC
International classification of primary care
LVEF
Linkerventrikelejectiefractie
Linkerventrikelejectiefractie.
PCI
Percutane coronaire interventie
Ook wel dotteren of ballondilatatie genoemd. Techniek waarbij een opblaasbare ballon op (bijna) dichtgeslibde plaatsen in de hartslagaders (kransslagaders) het bloedvat wat kan oprekken. Het doel van deze techniek is de doorbloeding van de hartspier weer beter op gang te brengen.
RCT
Randomized controlled trial
RNH
Registratienet Huisartsenpraktijken
Registratienet Huisartsenpraktijken.

Definities

BNP
B-type Natriuretic Peptide
Gerandomiseerde trial
Experimenteel onderzoek bij mensen om de werkzaamheid van (zorg)interventies aan te tonen waarbij een groep die de zorginterventie krijgt wordt vergeleken met een groep die de zorginterventie niet krijgt en waarbij het toeval bepaald in welke groep iemand terecht komt.
NTproBNP
N-terminal proB-type Natriuretic Peptide
Primaire doodsoorzaak
De ziekte of de gebeurtenis waarmee de aaneenschakeling van gebeurtenissen die tot de dood leidde, startte. Men spreekt hierbij wel van de onderliggende ziekte of het grondlijden (Bron: CBS).